A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
Clinical trial NCT04974827 · UNKNOWN
Trial details
- NCT number
- NCT04974827
- Sponsor
- Hunan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-20
- Primary completion
- 2023-05-20
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.